Sulfonylureas in the Treatment of Type 2 Diabetes Mellitus: A Fresh Look and New Insights

Diabetes Therapy - United States
doi 10.1007/s13300-020-00810-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sulfonylureas and Cardiovascular Complications of Type 2 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2014English

Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies: A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

New Insights Into the Pharmacological Treatment of Pediatric Patients With Type 2 Diabetes

Clinical Pediatric Endocrinology
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2018English

Sulfonylureas as Treatment Choice in Diabetes Mellitus : Where Are We Now?

Diabetes Updates
2019English

Honey as a Sole Treatment of Type 2 Diabetes Mellitus

Endocrinology & Metabolic Syndrome
2016English

Vildagliptin: Optimal Control in Type 2 Diabetes Mellitus Treatment

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Considering Gut Microbiota in Treatment of Type 2 Diabetes Mellitus

Gut Microbes
Infectious DiseasesMicrobiologyGastroenterology
2020English

Insulinization: A Promising Strategy for the Treatment of Type 2 Diabetes Mellitus

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy